期刊文献+

羟氯喹辅治狼疮性肾炎伴周围血管炎的临床观察 被引量:3

下载PDF
导出
摘要 目的比较羟氯喹(HCQ)与常规泼尼松、环磷酰胺(CTX)治疗狼疮性肾炎伴周围血管炎的疗效。方法52例狼疮性肾炎伴周围血管炎患者随机分为2组。对照组24例,采用泼尼松+CTX治疗;治疗组28例,采用泼尼松+CTX+HCQ治疗,观察治疗3个月及6个月的疗效。结果治疗3个月2组在周围血管炎临床症状改善及24 h尿蛋白定量、血肌酐(Scr)、血清白蛋白(Alb)、红细胞沉降率等方面差异无统计学意义(P>0.05)。治疗6个月后治疗组的临床症状改善及实验室指标变化较对照组有显著差异(P<0.01,P<0.05)。且抗ds-DNA、C_3等指标的改善亦优于对照组(P<0.05)。结论联合羟氯喹治疗狼疮性肾炎伴周围血管炎效果满意。
出处 《疑难病杂志》 CAS 2010年第7期522-523,共2页 Chinese Journal of Difficult and Complicated Cases
  • 相关文献

参考文献7

  • 1Ramos-Casals M, Nardi N, Lagrutta M, et al. Vasculitis in systemic lupus erythematosus: prevalence and clinical characteristics in 670 patients [J]. Medicine (Baltimore) ,2006,85(2) :95-104.
  • 2廖文俊,陈刚,付萌.系统性红斑狼疮性血管炎[J].中国皮肤性病学杂志,2009,23(4):249-251. 被引量:7
  • 3许晓燕,桑晓红.狼疮性肾炎的诊治分析[J].中国全科医学,2009,12(7):611-614. 被引量:12
  • 4Kasitanon N, Fine DM, Haas M, et al. Hydroxychloroquine use predicts complete renal remission within 12 months among patients treated with mycophenolate mofetil therapy for membranous lupus nephritis [ J ]. Lupus ,2006,15(6 ) :366-370.
  • 5Kasitanon N, Magder LS, Petri M. Predictors of survival in systemic lupus erythematosus [ J]. Medicine(Baltimore) ,2006,85 ( 3 ) : 147-156.
  • 6潘思思,刘蕊,刘湘源,吴凤霞,袁国华,苏茵,栗占国.系统性红斑狼疮患者的用药选择及其与肾脏损害相关性的回顾性分析[J].中华风湿病学杂志,2009,13(10):689-692. 被引量:10
  • 7Bertsias G, loannidis JP, Boletis J, et al. EULAR recommendations for the management of systemic lupus crythematosus. Report of a Task Force of the EULAR Standing Committee for International Clinical Studies Including Therapeutics [ J ]. Ann Rheum Dis ,2008,67 (2) : 195-205.

二级参考文献29

共引文献26

同被引文献26

  • 1翁燕蓉,彭才智,曾铁云,杭春风.甲基泼尼松龙和环磷酰胺联合冲击治疗狼疮肾炎的护理干预[J].湖北医药学院学报,2012,31(1):76-78. 被引量:10
  • 2汪志红,张素华,倪银星,吴静,王继旺,龚俐琳.羟氯喹增加胰岛素抵抗大鼠模型胰岛素敏感性的实验研究[J].重庆医科大学学报,2004,29(4):429-432. 被引量:7
  • 3Ioachimescu AG,Brennan DM,Hoar BM,et al.Serum uric acid is an independent predictor of all cause mortality in patients at high risk of cardiovascular disease:a preventive cardiology information system (PrdCIS) database cohort study[J].Arthritis Rheum,2008,58(2):623-630.
  • 4Choi HK,De Vera MA,Krishnan E.Gout and the risk of type 2 diabetes among men with a high cardiovascular risk profile[J].Rheumatology(Oxford),2008,47(10):1567-1570.
  • 5Rahman P,Gladman DD,Urowitz MB,et a1.The cholesterol lowering effect of antimalarial drugs is enhanced in patients with lupus taking corticosteroid drugs[J].Rheumatol,1999,26(2):325-330.
  • 6Costedoat-Chalumeau N,Leroux G,Piette JC,et a1.Why all systemic lupus erythematosus patients should be given hydroxychloroquine treatment[J].Joint Bone Spine,2010,77(1):4-5.
  • 7Costedoat-Chalumeau N,Amoura Z,Hulot J.et al.Hydroxychloroquine in systemic lupus erythematosus[J].Lancet,2007,369(9569):1257-1258.
  • 8李芳,姚建华,张风肖,孙丽君,陶杰梅.阿魏酸钠联合羟氯喹治疗老年类风湿关节炎的临床观察[J].中国全科医学,2007,10(17):1429-1431. 被引量:6
  • 9中华人民共和国卫生部.中药新药临床研究指导原则[S].,1997.147.
  • 10PETRI M. Systemic Lupus International Collaborating Chnic (SLIC C) :SLICC revision of the ACR classification criteria for SLE [ J~. Arthritis Rheum, 2009, 60 ( Suppl 10) :895.

引证文献3

二级引证文献31

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部